Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Catalent, Inc.

< Previous 1 2 3 4 5 6 Next >
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery... 
Tickers CTLT MRNA
From Business Wire News Releases
Catalent, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and... 
Tickers CTLT
From Business Wire News Releases
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Reports Second Quarter Fiscal 2021 Results
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Announces Second Quarter Fiscal Year 2021 Earnings Conference Webcast
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. to Present at November 2020 Virtual Investor Conferences
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Reports First Quarter Fiscal 2021 Results
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Announces First Quarter Fiscal Year 2021 Earnings Conference Webcast
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. to Present at September 2020 Virtual Investor Conferences
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Reports Fourth Quarter Fiscal 2020 Results
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2020 Net Revenue, Earnings Before Income Taxes, and Adjusted EBITDA Significantly Ahead of Its Previous Guidance
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and... 
Tickers CTLT MRNA
From Business Wire News Releases
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Announces Public Offering of Common Stock
Catalent, Inc. (“Catalent”) (NYSE:CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. to Present at June 2020 Virtual Investor Conferences
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. to Present at May 2020 Virtual Investor Conferences
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics Holdings Inc. (“Arcturus”, “the Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc. (NYSE: CTLT), the leading... 
Tickers ARCT CTLT
From Business Wire News Releases
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. Announces Third Quarter Fiscal Year 2020 Earnings Conference Webcast
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent Publishes Fiscal 2019 Corporate Responsibility Report
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene and therapies, and consumer... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. to Present at the Barclays Global Healthcare Conference
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health... 
Tickers CTLT
From Business Wire News Releases
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and... 
Tickers CTLT
From Business Wire News Releases
Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and... 
Tickers CTLT
From Business Wire News Releases
Catalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products,... 
Tickers CTLT
From Business Wire News Releases
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account